Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: Response to L-T4 treatment

Thyroid

Volumn 17, Issue 5, 2007, Pages 453-460

  Brenta, Gabriela ^a,c   Berg, Gabriela ^b   Arias, Pablo ^a   Zago, Valeria ^b   Schnitman, Marta ^a   Muzzio, Maria Luz ^b   Sinay, Isaac ^a   Schreier, Laura ^b  

^a HOSPITAL FRANCÉS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEVOTHYROXINE; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPOTHYROIDISM; INSULIN RESISTANCE; LIPASE; LIPOPROTEINS, LDL; MIDDLE AGED; THYROTROPIN; THYROXINE; TRIGLYCERIDES;

EID: 34249938682     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0302     Document Type: Article

References (66)

1. Cappola A, Ladenson P 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438-2444.
2. Kussi T, Taskinen MR, Nikkila EA 1988 Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 66:61-66.
3. Valdemarsson S, Nilsson-Ehle P 1987 Hepatic lipase and the clearing reaction: studies in euthyroid and hypothyroid subjects. Horm Metab Res 19:28-30.
4. Tan K, Shiu S, Kung A 1998 Effect of thyroid dysfunction on high-density lipoprotein subtraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein. J Clin Endocrinol Metab 83:2921-2924.
5. 3 in the degradation of LDL by cultured human skin fibroblast. J Clin Endocrinol Metab 48:887-889.
6. Scarabottolo L, Trezzi E, Roma P, Catapano AL 1986 Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis 59:329-333.
7. Duntas L 2002 Thyroid disease and lipids. Thyroid 12:287-293.
8. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534.
9. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228-238.
10. Rodondi N, Aujesky D, Vittinghoff V, Cornuz J, Bauer DC 2006 Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 119:541-551.
11. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 132:270-278.
12. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witzum J 1989 Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924.
13. Schreier LE, Sanguinetti S, Mosso H, Lopez G, Siri L, Wikinski R 1996 Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease. Clin Biochem 29:479-487.
14. Lempiäinen P, Mykkänen L, Pyörälä K, Laakso M, Kuusisto J 1999 Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100:123-128.
15. Sundaram V, Hanna A, Koneru L, Newman H, Falko J 1997 Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 82:3421-3424.
16. Diekman T, Demacker P, Kastelein J, Stalenhoef A, Wiersinga W 1998 Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 83:1752-1755.
17. Rochon C, Tauveron I, Dejax C, Benoit P, Capitan P, Fabricio A, Berry C, Champredon C, Thieblot P, Grizard J 2003 Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Colch) 104:7-15.
18. Brenta G, Arias P, Pisarev M, Guzmán Z, Schnitman M, Sinay I 2001 Sensibilidad a la insulina en pacientes atireóticas: efectos del tratamiento supresor con L-tiroxina y de la suspensión del mismo. RAEM 38:3-8.
19. Benvenga S, Cahnmann HJ, Robbins J 1990 Localization of the thyroxine binding sites in apolipoprotein B100 of human low density lipoproteins. Endocrinology 127:2241-2246.
20. Hanna AN, Feller DR, Witiak DT, Newman HA 1993 Inhibition of low density lipoprotein oxidation by thyronines and probuclo. Biochem Pharmacol 45:753-762.
21. Benvenga S, Robbins J 1996 Altered thyroid hormone binding to plasma lipoproteins in hypothyroidism. Thyroid 6:595-600.
22. Benvenga S, Cahnmann HJ, Rader D, Kindt M, Facchiano A, Robbins J 1994 Thyroid hormone binding to isolated apolipoproteins A-II, C-I, C-II, and C-III: homology in thyroxine binding sites. Thyroid 4:261-267.
23. Duntas L, Mantzou E, Koutras DA 2002 Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 12:1003-1007.
24. Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S, Tamai H, Miyauchi A, Kuma K, Hanafusa T 2003 Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. Clin Endocrinol (Oxf) 58:621-626.
25. Ito M, Takamatsu J, Sasaki I, Hiraiwa T, Fukao A, Murakami Y, Isotani H, Miyauchi A, Kuma K, Hanafusa T 2004 Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism. Am J Med 117:696-699.
26. Bakker S, ter Maaten JC, Popp-Snijders C, Slaets J, Heine R, Gans J 2001 The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 86:1206-1211.
27. 4 glucose transporter gene expression and NIDDM in rats. Endocrinology 138:1204-1214.
28. Huang MT, Lardy HA 1981 Effects of thyroid states on the cori cycle, glucose-alanine cycle, and futile cycling of glucose metabolism in rats. Arch Biochem Biophys 209:41-51.
29. Dessein PH, Joffe BI, Stanwix AE 2004 Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 14:443-446.
30. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K 2005 Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J 52:89-94.
31. Alsayed A, Ali N, Abbas Y, Alfadhli E 2006 Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocr J 53:653-657.
32. Danese MD, Ladenson PW, Meinert CL, Powe NR 2000 Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85:2993-3001.
33. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Muller B 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double-blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 86:4860-4866.
34. Caraccio N, Ferrannini E, Monzani F 2002 Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 87:1533-1538.
35. Assmann G, Schriewer H, Schmitz G, Hagele EO 1983 Quantification of high density lipoprotein cholesterol by precipitation with phosphotungstic acid-MgC12. Clin Chem 29:2026-2030.
36. Assmann G, Jabs H, Kohnert U, Nolte W, Schriewer H 1984 LDL (low density lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly(vinyl sulphate). Clin Chim Acta 140:77-83.
37. World Health Organization 1985 Diabetes Mellitus: Report of a WHO Study Group. World Health Organization, Geneva (Tech. Rep. Ser. no. 727).
38. Nilsson-Ehle P, Ekman R 1977 Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3:194-200.
39. Schumaker V, Puppione D 1986 Sequential flotation ultra-centrifugation. In: Segrest JP, Alberts JJ (eds) Methods in Enzymology. Academic Press, London, pp 155-160.
40. Noble R 1968 Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 9:693-700.
41. Bartlett G 1959 Phosphorus assay in column chromatography. J Biol Chem 234:466-468.
42. Markwell MA, Hass SM, Bieber LL, Tolbert NE 1978 A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210.
43. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J 1988 Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 29:1603-1611.
44. Landin B, Nilsson A, Twu JS, Schotz MC 1984 A role for hepatic lipase in chylomicron and high density lipoprotein phospholipid metabolism. J Lipid Res 25:559-563.
45. Krapp A, Ahle S, Kersting S, Hua Y, Kneser K, Nielsen M, Gliemann J, Beisiegel U 1996 Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J Lipid Res 37:926-936.
46. Zambon A, Deeb SS, Bensadoun A, Foster KE, Brunzell JD 2000 In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J Lipid Res 41:2094-2099.
47. Berg GA 2001 Lipasa hepática, efectos sobre el metabolismo lipídico y lipoproteico. Acta Bioquím Clín Latinoam 35:201-224.
48. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD 2003 Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 44:1279-1286.
49. Kihara S, Wolle J, Ehnholm C, Chan L, Oka K 1993 Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells. J Lipid Res 34:961-970.
50. Abrams JJ, Grundy SM, Ginsberg H 1981 Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. J Lipid Res 22:307-322.
51. Krauss RM, Levy RI, Fredrickson DS 1974 Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest 54:1107-1124.
52. Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P 1983 Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol (Copenh) 104:50-56.
53. Lam KS, Chan MK, Yeung RT 1986 High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction-effects of treatment. Q J Med 59:513-521.
54. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW 1993 Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13:720-728.
55. Dichek HL, Qian K, Agrawal N 2004 Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Arterioscler Thromb Vasc Biol 24:1696-1702.
56. Lewis GF, Murdoch S, Uffelman K, Naples M, Szeto L, Albers A, Adeli K, Brunzell JD 2004 Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone. Diabetes 53:2893-2900.
57. Berg GA, Siseles N, Gonzalez AI, Ortiz OC, Tempone A, Wikinski RW 2001 Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause 8:51-57.
58. Rosental SB, Schreier LE, Halperin H, Berg G, Paglione AM, Ruiz M, Wikinski RL 1995 Low density lipoprotein rich in triglycerides and hepatic lipase activity in insulin-dependent diabetic patients. Medicina (B Aires) 55:317-323.
59. Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W, Kreuzer J 2001 Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 104:3057-3062.
60. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD 2003 Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 14:179-189.
61. Berneis K, Krauss RM 2002 Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43:1363-1379.
62. Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM 1996 Differences in receptor binding of low density lipoprotein subtractions. Arterioscler Thromb Vasc Biol 16:769-801.
63. Nigon F, Lesnik P, Rouis M, Chapman MJ 1991 Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with cellular LDL receptor. J Lipid Res 32:1741-1753.
64. Aviram M, Lund-Katz S, Phillips MC, Chait A 1988 The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem 263:16842-16848.
65. 2 cholesterol in normolipidemic with coronary artery disease. Arterioscler Thromb Vasc Biol 15:1043-1048.
66. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A 1992 Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186.